Ballicules.com

Brompheniramine

DIMETAPP

What it isFirst-generation H1 antagonist; allergic rhinitis and cold symptoms.

Why this oneEffective and inexpensive, widely available in combination products.

What limits itAnticholinergic burden and sedation, so it is poor in the elderly. Impairs driving.

FDA-approved for

FDA label

FDA dosingPopulationStartTargetMax
Hay fever symptoms (runny nose, sneezing, itchy nose/throat, itchy watery eyes)Adults & children ≥12 yr20 mL (4 mg) PO Q4H20 mL Q4H PRN6 doses/24 h
Hay fever symptomsChildren 6 to <12 yr10 mL (2 mg) PO Q4H10 mL Q4H PRN6 doses/24 h
Hay fever symptomsChildren <6 yrDo not useDo not useDo not use

Renal Undefined

Hepatic Undefined

Max 6 doses per 24 hours

Instructions

Contraindications

Cautions

Adverse reactions

Pregnancy If pregnant or breast-feeding, ask a health professional before use.

Lactation If pregnant or breast-feeding, ask a health professional before use.

NO BOXED WARNINGS

Principal riskAnticholinergic burden and sedation

Classes and tags

Clinical profile

Direct muscarinic antagonism1 / 4

Mechanism of action: Brompheniramine ballicule

Brompheniramine ballicule: receptor binding, kinetics and half-life diagram

Open Brompheniramine in the interactive console ↗

Memory aids: mascots and interaction avatars

Brompheniramine DIMETAPP mascot mnemonic cartoon
“Broom Dime tappin’”

Open Brompheniramine in the interactive console ↗